Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.
Nil AlbiolSilvana NovelliAnna MozosMarta PratcoronaRodrigo MartinoJorge SierraPublished in: Journal of medical case reports (2021)
Venetoclax monotherapy seems not enough to control the disease progression under CNS involvement and other treatments should be investigated.
Keyphrases
- dendritic cells
- chronic lymphocytic leukemia
- immune response
- regulatory t cells
- acute lymphoblastic leukemia
- acute myeloid leukemia
- diffuse large b cell lymphoma
- blood brain barrier
- multiple myeloma
- hodgkin lymphoma
- low grade
- combination therapy
- atomic force microscopy
- randomized controlled trial
- clinical trial
- mass spectrometry
- study protocol